ストックスクリーナーアプリを入手
7.00
0.99%
-0.06
前日終値:
$7.06
開ける：
$7.02
24時間の取引高:
28,577
Relative Volume:
0.37
時価総額：
$402.44M
収益：
$154.57M
当期純損益:
$15.07M
株価収益率:
25.93
EPS:
0.27
ネットキャッシュフロー:
$10.92M
1週間 パフォーマンス:
-1.13%
1か月 パフォーマンス:
+1.01%
6か月 パフォーマンス:
-9.69%
1年 パフォーマンス:
+10.43%
1日の値動き範囲:
$6.92
$7.11
1週間の範囲:
$6.92
$7.17
52週間の値動き範囲:
$5.54
$9.155
Kamada Ltd Stock (KMDA) Company Profile
KMDA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
6.9769 | 407.23M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
125.17 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.58 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.99 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.70 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
492.28 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | 開始されました | The Benchmark Company | Buy |
| 2024-07-03 | 開始されました | Stifel | Buy |
| 2018-02-02 | 開始されました | Chardan Capital Markets | Buy |
Kamada Ltd (KMDA) 最新ニュース
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat
Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World
Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN
Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga
Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com
Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда
Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда
Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда
Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber
Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks
Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда
Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда
Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria
Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com
Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com
Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks
Kamada secures $10-14 million Canadian supply tender extension - Investing.com
Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire
Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation - MSN
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
Breakout Zone: How geopolitical tensions affect Kamada Ltd stock2025 Earnings Surprises & Consistent Return Investment Signals - moha.gov.vn
Precision Trading with Kamada Ltd. (KMDA) Risk Zones - Stock Traders Daily
Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World
FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World
What is HC Wainwright's Forecast for Kamada FY2025 Earnings? - MarketBeat
Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World
Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks
Sidoti Csr Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria
H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus By Investing.com - Investing.com South Africa
Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga
Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com
Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks
Kamada reiterates FY25 revenue guidance $178M-$182M - TipRanks
Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026 - TipRanks
Kamada (KMDA) Halts Phase 3 Trial of Inhaled AAT for Alpha-1 Ant - GuruFocus
Kamada reiterates 2025 FY revenue guidance of $178M-$182M - marketscreener.com
Kamada Reiterates 2025 FY Revenue Guidance Of $178M-$182M - TradingView
Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial By Investing.com - Investing.com Canada
Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial - Investing.com
Kamada (NASDAQ: KMDA) drops inhaled AAT study, reaffirms $178M-$182M 2025 revenue - Stock Titan
Shareholders May Not Be So Generous With Kamada Ltd.'s (TLV:KMDA) CEO Compensation And Here's Why - simplywall.st
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average – Time to Sell? - Defense World
Technical Reactions to KMDA Trends in Macro Strategies - news.stocktradersdaily.com
Kamada updates proxy statement ahead of annual shareholder meeting By Investing.com - Investing.com Australia
Kamada updates proxy statement ahead of annual shareholder meeting - Investing.com
Kamada Ltd (KMDA) 財務データ
収益
当期純利益
現金流量
EPS
2.71%
1.90%
大文字化:
|
ボリューム (24 時間):